News
News
X
Evidence in favour of naproxen heart risk fails to bring label change
https://pharmaphorum.com/news/evidence-in-favour-of-naproxen-heart-risk-fails-to-bring-label-change/
X
Safety of diabetes drug Onglyza probed
https://pharmaphorum.com/news/safety-of-diabetes-drug-onglyza-probed/
X
NICE lowers threshold for statin prescription
https://pharmaphorum.com/news/nice-lowers-threshold-for-statin-prescription/
X
$1.3 billion acquisition focused on hospital pain drug
https://pharmaphorum.com/news/1-3-billion-acquisition-focused-on-hospital-pain-drug/
X
FDA meeting with India’s government produces results
https://pharmaphorum.com/news/fda-meeting-with-india-s-government-produces-results/
X
Jazz starts construction of Irish plant to provide 50 new pharma jobs
https://pharmaphorum.com/news/jazz-starts-construction-of-irish-plant-to-provide-50-new-pharma-jobs/
X
Roche wins Herceptin injunction against Biocon and Mylan
https://pharmaphorum.com/news/roche-wins-herceptin-injunction-against-biocon-and-mylan/